Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Other Working Capital Changes (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Other Working Capital Changes for 2 consecutive years, with -$173000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes rose 34.72% to -$173000.0 in Q4 2025 year-over-year; TTM through Oct 2025 was $1.4 million, a N/A change, with the full-year FY2025 number at $1.9 million, up 494.88% from a year prior.
  • Other Working Capital Changes was -$173000.0 for Q4 2025 at Kestra Medical Technologies, down from -$140000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.6 million in Q2 2025 to a low of -$331000.0 in Q2 2024.